In summary, our results suggest that ZNF692 upregulates c-Myc and CyclinA1 by activating EMT signaling pathway, promotes the proliferation and resistance to apoptosis of prostate cancer cells, and enhances cell invasion and migration. This evidence concerns the gene ZNF692 and Familial prostate cancer.